![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07D 267/14 | |
C07D 413/04 | |||
C07D 413/12 | |||
C07D 413/14 | |||
C07D 498/04 | |||
A61K 31/553 |
(11) | Patento numeris | 2726469 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 12735400.9 |
Europos patento paraiškos padavimo data | 2012-06-29 | |
(97) | Europos patento paraiškos paskelbimo data | 2014-05-07 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2015-08-12 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2012/045021 |
Data | 2012-06-29 |
(87) | Numeris | WO 2013/006463 |
Data | 2013-01-10 |
(30) | Numeris | Data | Šalis |
201161503980 P | 2011-07-01 | US |
(72) |
CORKEY, Britton, Kenneth, US
ELZEIN, Elfatih, US
JIANG, Robert, H., US
KALLA, Rao, V., US
KOLTUN, Dmitry, US
LI, Xiaofen, US
MARTINEZ, Ruben, US
PARKHILL, Eric, Q., US
PERRY, Thao, US
ZABLOCKI, Jeff, US
VENKATARAMANI, Chandrasekar, US
GRAUPE, Michael, US
GUERRERO, Juan, US
|
(73) |
Gilead Sciences, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
(54) | OXAZEPINES AS ION CHANNEL MODULATORS |
OXAZEPINES AS ION CHANNEL MODULATORS |